Metformin is a safe and effective oral medication for people with type 2 diabetes. Here's how it can help regulate ...

Researchers have concluded that the oral diabetes medication metformin is just as safe for babies and their pregnant mothers as using insulin. The study tracked the long-term health of 10,117 children ...

BOSTON—Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to ...

Like any medication, metformin can interact with other drugs you might be taking. If you're a woman, this one interaction in particular may be of concern.

March 22, 2012 — Long-term treatment with metformin is safe for preventing or delaying the development of type 2 diabetes, according to an article published in the April issue of Diabetes Care. New ...

WASHINGTON, DC (REUTERS) Men can take the widely prescribed diabetes drug metformin without fear of causing birth defects in their children, according to results of a large study published on October ...

(HealthDay News) — For individuals with impaired kidney function, evidence suggests that metformin use is safe in those with mild or moderate disease, according to a review published in the Dec. 24/31 ...

Potential fathers with type 2 diabetes can be reassured that taking the drug metformin is not associated with birth defects in their offspring, concludes a large study of more than 3 million ...

In this paper, [4] the authors studied a community-based cohort of patients with a diagnosis of diabetes mellitus and a postdiagnosis serum creatinine measurement who were receiving care in the ...

Though Ozempic launched into the pop culture lexicon in late 2022, the drug, once known for its catchy commercial jingle, achieved Food & Drug Administration approval for A1C management in 2017.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...